ICP-MS法测定心可舒片中的微量元素

为建立准确快速测定心可舒片中微量元素含量的方法,对该药生产进行质量控制,并为合理用药提供依据,采用电感耦合等离子体质谱法(ICP-MS),对心可舒片中的21种元素进行了分析。结果表明,心可舒片对心血管病的疗效与其中的微量元素有关。     

复方丹参片生产中丹酚酸B的快速测定

为建立制药企业在生产复方丹参片时的快速质量控制方法,用TLC及反相HPLC法,对在不同处理条件下的复方丹参片样品中丹酚酸B进行了定性、定量分析,同时优化了色谱条件,提高了测定的准确性。结果表明,甲醇超声处理复方丹参片粉末20 min(1次),再用高纯水超声处理20 min(2次);流动相V(甲醇) V(乙腈) (V甲酸) V(水)=25 10 1 64,波长286 nm。本法线性好,准确度高,简便快捷经济,可用于生产该药的内在质量监测。     

UPLC–Q‐TOF/MS characterization of efficacy substances on osteoblasts differentiation and function in rat serum after administration of Wang‐Bi tablet

Wang‐Bi tablet (WB) is popularly used for the treatment of rheumatoid arthritis. However, few studies have been carried out on its active ingredients and mechanism. In this study, the effect of WB medicated serum on the changes in differentiation and function in osteoblast was investigated, the results showed that WB induced the production of ALP and mineralized nodules to promote the final maturation of osteoblasts and enhance the function of osteoblasts. The potential mechanism may that WB significantly inhibits gene expressions of RANKL and miR‐141, up‐regulates the gene expressions of RUNX2 and OPG, decreases expression of DKK‐1 and increases levels of β‐catenin protein to promote the activation of Wnt/β‐catenin signaling pathways, which enhances osteogenesis and bone repair function. To investigate which compounds contributed to the activity and mechanisms, a total of 138 compounds were characterized from WB, and 13 parent molecules and eight metabolites in rat serum were rapidly characterized by UPLC–Q‐TOF/MS. Total glycosides of paeony, loganin, α‐linolenic acid, linoleic acid and naringin from WB may contribute to the actions on osteoblasts according to our study and literature review. Our research provides a method to explore the bioactive ingredients and action mechanisms of WB.     

Controlled release matrix tablet formulation using synthesized N-acyl Thiolated Chitosan derivatives

Chitosan derivative was successively synthesized by initial preparation of acyl thiourea reagent using ammonium thiocyanate and making it to react with at primary amino groups of chitosan and then reduced to yield Thiolated Chitosan. Due to the formation of disulphide bonds with mFucus glycoproteins, mucoadhesiveness is augmented. The thiol groups were then quantified using Ellman’s reagent. The derivatives inherit good swelling property in neutral and alkaline media. The different derivatives containing thiol groups were formulated into tablets using reference drug for evaluation. The Thiolated Chitosan display in situ gelling features due to the pH-dependent (alkaline pH) formation of inter-molecular disulphide bonds which makes the application of Thiolated Chitosan on intestinal mucosa and can guarantee prolonged controlled release of embedded therapeutic ingredients.     

Simultaneous determination of eight bioactive components in rat plasma after oral administration of Yan‐Ke‐Ning‐Tablet by liquid chromatography coupled with Q‐Exactive Orbitrap tandem mass spectrometry

A rapid, sensitive and reliable quantitative method based on ultra‐high performance liquid chromatography coupled with Q‐Exactive Orbitrap tandem mass spectrometry was developed for simultaneous determination of berberine, berberrubine, palmatine, jatrorrhizine, columbamine, baicalin, baicalein and wogonin in rat plasma after oral administration with Yan‐Ke‐Ning‐Tablet (YKNT). After precipitation with acetonitrile, the plasma samples were separated on a reverse‐phase C₁₈ column with 1 mm ammonium acetate containing 0.2% acetic acid–acetonitrile as mobile phase. Calibration curves showed good linearity (r > 0.9983) over the tested concentration ranges of 0.5–200 ng/mL for berberine, berberrubine, palmatine, jatrorrhizine and columbamine, and 1–300 ng/mL for baicalin, baicalein and wogonin. The precision (relative standard deviation) at three different concentration levels was <12.15% and the accuracy (relative error) ranged from ?8.24 to 10.85%. No matrix effects were observed with matrix effect value ranging from 89.23 to 107.68%. The extraction recovery was in the range of 82.34–92.31%. The validated assay was further successfully applied to the pharmacokinetic study of these components after oral administration of YKNT. The present study provides the pharmacokinetic profiles of major bioactive components found in YKNT, and provides valuable information regarding the chemical components that were absorbed into plasma, which will be helpful for understanding the therapeutic effects of YKNT.     

A comparative pharmacokinetic study of three flavonoids and three anthraquinones in normal and gastrointestinal motility disorders rat plasma after the oral administration of Wei‐Chang‐Shu tablet using high‐performance liquid chromatography–tandem mass spectrometry

A simple, fast and reliable high‐performance liquid chromatography–tandem mass spectrometry method was developed and validated for the simultaneous quantification and pharmacokinetic study of three flavonoids (liquiritigenin, isoliquiritigenin and formononetin) and three anthraquinones (emodin, rhein and aloe‐emodin), which are the bioactive ingredients of Wei‐Chang‐Shu tablet found in rat plasma. After extraction by liquid–liquid extraction with ethyl acetate, chromatographic separation was achieved on an Agilent Zorbax SB‐C₁₈ column (4.6 × 150 mm, 5 μm) at a flow rate of 1 mL/min by gradient elution using 0.1% aqueous acetic acid and acetonitrile. The detection was performed using a triple quadrupole mass spectrometer equipped with electrospray ionization source in the negative ionization and selected reaction monitoring mode. Method validation was performed in terms of specificity, carryover, linearity (r > 0.99), intra−/inter‐day precision (1.0–10.1%), accuracy (relative error, <7.6%), stability (0.6–13.2%), extract recovery (74.9–91.9%) and matrix effect (89.1–109%). The lower limits of quantification of the six analytes varied from 0.92 to 10.4 ng/mL. The validated method was successfully applied to compare the pharmacokinetic properties of Wei‐Chang‐Shu tablet in normal rats and in rats with gastrointestinal motility disorders. The results indicated that there were obvious differences in the pharmacokinetic behavior between normal and model rats. This study will be helpful in the clinical application of Wei‐Chang‐Shu tablet.     

Tb3+敏化化学发光法测定氟罗沙星

利用Tb3+能大大增强Ce*$-H2SO3-FLX的化学发光,建立了一种简单、快速、高灵敏度、高选择性的测定氟罗沙星的新方法,氟罗沙星浓度在2.0×10-9～8.0×10-8 mol/L范围内时,发光强度与氟罗沙星浓度呈良好的线性关系,方法的检出限为8.3×10-10 mol/L,对2.0×10-8 mol/L的氟罗沙星平行测定11次,相对标准偏差为1.2%.并用该方法测定了沃尔得及天方片剂中氟罗沙星的含量,不经任何预处理,直接测定了尿样中氟罗沙星的含量及回收率,结果令人满意.     

富锌排铅咀嚼片临床排铅效果研究

采用自身对照及组间对照法,对富锌排铅咀嚼片(RZLR)进行了临床排铅效果研究。将60例高血铅试食者随机分成试食组和对照组,每组3 0例,试食组口服RZLR片,对照组口服安慰剂。口服一个月后,试食者乏力、头晕、失眠、关节痛等主要症状有较好的改善,血红蛋白、红细胞、白细胞、血清总蛋白、白蛋白、谷草转氨酶、谷丙转氨酶、尿素氮、肌酐及尿常规等各项临床检验指标均在正常范围,血铅下降81 5 μg/L ,尿铅排出增加1 6 0 μg/L ,两组比较有显著性差异(P <0 0 0 1 ) ,说明RZLR片对试食者身体健康无不良影响,有促进人体排铅作用     

Qualitative and quantitative analysis of the major constituents in Jin‐Mu‐Gan‐Mao tablet by high‐performance liquid chromatography with diode‐array detection and quadrupole time‐of‐flight tandem mass spectrometry

Jin‐Mu‐Gan‐Mao tablet is a well‐known traditional Chinese medicinal preparation, which has been used to treat the common cold in China. In this study, a systematic method was established for the qualitative and quantitative analysis of the major constituents in Jin‐Mu‐Gan‐Mao tablet. First, a method of high‐performance liquid chromatography with diode‐array detection and quadrupole time‐of‐flight mass spectrometry was developed for identification of the multi‐constituents. Thirty‐one compounds including ten phenolic acids, 18 flavonoids, and three iridoid glycosides were clearly identified by comparison with the reference standards, and 11 compounds were deduced by comparison with the literature data. Second, a new quantitative analysis method of Jin‐Mu‐Gan‐Mao tablet was established by high‐performance liquid chromatography with diode‐array detection. Twelve compounds, either with high contents or strong bioactivities, were chosen as marker components. This analytical method was validated through intra‐ and interday precision, repeatability, and stability, with respective relative standard deviations less than 1.74, 2.54, 2.44, and 2.48%. The limits of detection and quantification were less than 0.327 and 0.881 μg/mL, respectively. The overall recoveries ranged from 97.04–102.76% (relative standard deviation ≤ 2.91%). Then this validated method was applied to determine ten batches of Jin‐Mu‐Gan‐Mao tablet. The results indicated that these new approaches can be applicable for the qualitative and quantitative analysis of Jin‐Mu‐Gan‐Mao tablet.     

测量复方药物溶出度的全自动药物溶出度测定仪

自行设计组装了一套可以同时测定复方药剂的全自动药物溶出度测定仪。该仪器由光学检测系统（由光源、流动型吸收池，小型光谱仪组成）、自动进样系统、控制与数据处理系统和机械搅拌系统4部分组成。光学系统的检测器是线阵电荷耦合器件（CCD），故可进行同时全光谱采集。数据处理部分采用了自行设计的基于径向基函数的人工神经网络进行浓度预测。用本装置对市售复方药剂鲁南贝特进行的溶出度测量表明，测量的精密度高，准确度较高，分析速度快，样品无需前处理。